Anne Derache

940 citations

20 papers · 466 indexed · h-index 15

Co-authors: Anne‐Geneviève Marcelin Vincent Cálvez Christine Katlama Isabelle Malet Collins Iwuji Anne Simon François Dabis Túlio de Oliveira
Topics: HIV Research and Treatment (19 papers)HIV/AIDS drug development and treatment (19 papers)HIV/AIDS Research and Interventions (15 papers)
Cited by: Virology Infectious Diseases Hepatology
Journals: PLoS ONE Clinical Infectious Diseases The Journal of Infectious Diseases
Partner nations: France South Africa United Kingdom

In The Last Decade

Anne Derache

20 papers receiving 461 citations

Peers

Countries citing papers authored by Anne Derache

Since Specialization

Citations

This map shows the geographic impact of Anne Derache's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Derache with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Derache more than expected).

Fields of papers citing papers by Anne Derache

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Derache. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Derache. The network helps show where Anne Derache may publish in the future.

Co-authorship network of co-authors of Anne Derache

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Derache. A scholar is included among the top collaborators of Anne Derache based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Derache. Anne Derache is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	HIV-1 Evolutionary Dynamics under Nonsuppressive Antiretroviral Therapy 2022 ·mBio ·Steven A. Kemp,Oscar Charles,Anne Derache,(unknown),Darren P. Martin,Collins Iwuji,John Adamson,Katya Govender,Túlio de Oliveira,François Dabis,Deenan Pillay,Richard A. Goldstein,Ravindra K. Gupta	4
2	T cell derived HIV-1 is present in the CSF in the face of suppressive antiretroviral therapy 2021 ·PLoS Pathogens ·Gila Lustig,Sandile Cele,Farina Karim,Anne Derache,(unknown),Khadija Khan,Bernadett I. Gosnell,Mahomed‐Yunus S. Moosa,(unknown),Suzaan Marais,Prakash Jeena,Katya Govender,John Adamson,Henrik N. Kløverpris,Ravindra K. Gupta,Rohen Harrichandparsad,Vinod Patel,Alex Sigal	28
3	Clinical Impact of Pretreatment Human Immunodeficiency Virus Drug Resistance in People Initiating Nonnucleoside Reverse Transcriptase Inhibitor–Containing Antiretroviral Therapy: A Systematic Review and Meta-analysis 2020 ·The Journal of Infectious Diseases ·Silvia Bertagnolio,Lucas E. Hermans,Michael R. Jordan,Santiago Ávila‐Ríos,Collins Iwuji,Anne Derache,Éric Delaporte,Annemarie M. J. Wensing,Theresa Aves,Sayem Borhan,Alvin Leenus,Neil Parkin,Meg Doherty,Seth Inzaule,Lawrence Mbuagbaw	44
4	Human Immunodeficiency Virus-1 Viral Load Is Elevated in Individuals With Reverse-Transcriptase Mutation M184V/I During Virological Failure of First-Line Antiretroviral Therapy and Is Associated With Compensatory Mutation L74I 2019 ·The Journal of Infectious Diseases ·John Gregson,Soo‐Yon Rhee,Rawlings Datir,Deenan Pillay,Carlo Federico Perno,Anne Derache,(unknown),Ravindra K. Gupta	8
5	Impact of Next-generation Sequencing Defined Human Immunodeficiency Virus Pretreatment Drug Resistance on Virological Outcomes in the ANRS 12249 Treatment-as-Prevention Trial 2018 ·Clinical Infectious Diseases ·Anne Derache,Collins Iwuji,Kathy Baisley,Siva Danaviah,Anne‐Geneviève Marcelin,Vincent Cálvez,Túlio de Oliveira,François Dabis,Kholoud Porter,Deenan Pillay	46
6	Predicted antiviral activity of tenofovir versus abacavir in combination with a cytosine analogue and the integrase inhibitor dolutegravir in HIV-1-infected South African patients initiating or failing first-line ART 2018 ·Journal of Antimicrobial Chemotherapy ·Anne Derache,Collins Iwuji,Siva Danaviah,Jennifer Giandhari,Anne‐Geneviève Marcelin,Vincent Cálvez,Túlio de Oliveira,François Dabis,Deenan Pillay,Ravindra K. Gupta	14
7	Virological Outcomes of Second-line Protease Inhibitor–Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis 2017 ·Clinical Infectious Diseases ·Dami A. Collier,Collins Iwuji,Anne Derache,Túlio de Oliveira,Nonhlanhla Okesola,Alexandra Calmy,François Dabis,Deenan Pillay,Ravindra K. Gupta	30
8	Qualitative and quantitative HIV antibodies and viral reservoir size characterization in vertically infected children with virological suppression 2016 ·Journal of Antimicrobial Chemotherapy ·Joséphine Brice,Mariam Sylla,Sophie Sayon,(unknown),Djeneba Fofana,Robert L. Murphy,Sidonie Lambert-Niclot,Ève Todesco,(unknown),Francis Barin,Souleymane Diallo,Deenan Pillay,Anne Derache,Vincent Cálvez,Anne‐Geneviève Marcelin,Almoustapha Issiaka Maïga	12
9	Phenotype, Genotype, and Drug Resistance in Subtype C HIV-1 Infection 2015 ·The Journal of Infectious Diseases ·Anne Derache,Carole L. Wallis,Saran Vardhanabhuti,John Bartlett,Nagalingeswaran Kumarasamy,David Katzenstein	9
10	HIV Drug Resistance Mutations in Proviral DNA from a Community Treatment Program 2015 ·PLoS ONE ·Anne Derache,Hyoung‐Shik Shin,(unknown),Elizabeth White,Dennis Israelski,Jeffrey D. Klausner,A.H. Freeman,David Katzenstein	36
11	Genetic barriers for integrase inhibitor drug resistance in HIV type-1 B and CRF02_AG subtypes. 2009 ·Antiviral Therapy ·(unknown),Isabelle Malet,Cathia Soulié,Anne Derache,(unknown),Bahia Amellal,Luba Tchertanov,Olivier Delelis,Laurence Morand‐Joubert,(unknown),Robert L. Murphy,Mamadou Cissé,Christine Katlama,Vincent Cálvez,Anne‐Geneviève Marcelin	42
12	Resistance-Associated Mutations to Etravirine (TMC-125) in Antiretroviral-Naive Patients Infected with Non-B HIV-1 Subtypes 2009 ·Antimicrobial Agents and Chemotherapy ·Almoustapha Issiaka Maïga,Diane Descamps,Laurence Morand‐Joubert,Isabelle Malet,Anne Derache,Mamadou Cissé,(unknown),(unknown),(unknown),Marc Wirden,Anatole Tounkara,(unknown),Christine Katlama,Dominique Costagliola,Bernard Masquelier,Vincent Cálvez,Anne‐Geneviève Marcelin	35
13	Genetic barriers for integrase inhibitor drug resistance in HIV type-1 B and CRF02_AG subtypes 2009 ·Antiviral Therapy ·(unknown),Isabelle Malet,Cathia Soulié,Anne Derache,(unknown),Bahia Amellal,Luba Tchertanov,Olivier Delelis,Laurence Morand‐Joubert,Jean‐François Mouscadet,Robert L. Murphy,Mamadou Cissé,Christine Katlama,Vincent Cálvez,Anne‐Geneviève Marcelin	34
14	Comparison of two genotypic algorithms to determine HIV‐1 tropism^* 2008 ·HIV Medicine ·Cathia Soulié,Anne Derache,(unknown),Anne‐Geneviève Marcelin,Guislaine Carcelain,Anne Simon,Christine Katlama,Vincent Cálvez	14
15	Structural effects of amino acid variations between B and CRF02‐AG HIV‐1 integrases 2008 ·Journal of Medical Virology ·Isabelle Malet,Cathia Soulié,Luba Tchertanov,Anne Derache,Bahia Amellal,Ousmane Traoré,Anne Simon,Christine Katlama,Jean‐François Mouscadet,Vincent Cálvez,Anne‐Geneviève Marcelin	22
16	Primary genotypic resistance of HIV-1 to the maturation inhibitor PA-457 in protease inhibitor-experienced patients 2007 ·AIDS ·Isabelle Malet,Marc Wirden,Anne Derache,Anne Simon,Christine Katlama,Vincent Cálvez,Anne‐Geneviève Marcelin	18
17	HIV drug resistance after the use of generic fixed-dose combination stavudine/lamivudine/nevirapine as standard first-line regimen 2007 ·AIDS ·Anne‐Geneviève Marcelin,B Jarrousse,Anne Derache,(unknown),(unknown),(unknown),(unknown),Almoustapha Issiaka Maïga,Guislaine Carcelain,Gilles Peytavin,Christine Katlama,Vincent Cálvez	24
18	Genetic Diversity and Drug Resistance Mutations in HIV type 1 from Untreated Patients in Bamako, Mali 2007 ·Antiviral Therapy ·Anne Derache,Ousmane Traoré,(unknown),(unknown),Roland Tubiana,Anne Simon,Ana Canestri,Guislaine Carcelain,Christine Katlama,Vincent Cálvez,Mamadou Cissé,Anne‐Geneviève Marcelin	20
19	Risk Factors for Selection of the L74I Reverse Transcriptase Mutation in Human Immunodeficiency Virus Type 1-Infected Patients 2006 ·Antimicrobial Agents and Chemotherapy ·Marc Wirden,Bénédicte Roquebert,Anne Derache,Anne Simon,Claudine Duvivier,Jade Ghosn,Stéphanie Dominguez,(unknown),Zaïna Ait-Arkoub,Christine Katlama,Vincent Cálvez,Anne‐Geneviève Marcelin	7
20	Clonal analyses of HIV quasispecies in patients harbouring plasma genotype with K65R mutation associated with thymidine analogue mutations or L74V substitution 2005 ·AIDS ·Marc Wirden,Isabelle Malet,Anne Derache,Anne‐Geneviève Marcelin,Bénédicte Roquebert,Anne Simon,Myriam Kirstetter,(unknown),Christine Katlama,Vincent Cálvez	19

About Anne Derache

Anne Derache is a scholar working on Virology, Infectious Diseases and Hepatology, having authored 20 papers that have together received 466 indexed citations. Recurring topics across this work include HIV Research and Treatment (19 papers), HIV/AIDS drug development and treatment (19 papers) and HIV/AIDS Research and Interventions (15 papers). The work is most often cited by research in Virology (422 citations), Infectious Diseases (435 citations) and Hepatology (18 citations). Anne Derache has collaborated with scholars based in France, South Africa and United Kingdom. Frequent co-authors include Anne‐Geneviève Marcelin, Vincent Cálvez, Christine Katlama, Isabelle Malet, Collins Iwuji, Anne Simon, François Dabis, Túlio de Oliveira, Mamadou Cissé and Cathia Soulié. Their work appears in journals such as PLoS ONE, Clinical Infectious Diseases and The Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact